Join
Live feed
·
PRReleasevia Quantisnow
Medtronic plc. logo
Orchestra BioMed Holdings Inc. logo

Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT™ for the Treatment of Hypertension in Pacemaker Patients

ByQuantisnow·Wall Street's wire, on your screen.
MDT· Medtronic plc.OBIO· Orchestra BioMed Holdings Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MDT (Medtronic plc.), OBIO (Orchestra BioMed Holdings Inc.) and more on Quantisnow.